GREG PYSZCZYMUKA
CIK 1952920 · Chief Commercial Officer · last filed 2025-12-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$77.6K
Companies
2
Total Filings
17
Lifetime Open-Market Net
$46.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc (EVOK) Delisted | Director | — | $11.00 | — | $0 | 3 | 2025-12-17 |
| AYTU | Chief Commercial Officer | 36,102 | $2.15 | $77.6K | $46.9K | 14 | 2025-10-07 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-02 | AYTU | Exer (M) | +209 | $0 | EDGAR |
| 2023-10-03 | AYTU | Exer (M) | +208 | $0 | EDGAR |
| 2023-08-15 | AYTU | Grant (A) | — | $0 | EDGAR |
| 2023-07-06 | AYTU | Exer (M) | +208 | $0 | EDGAR |
| 2023-06-20 | AYTU | Exer (M) | +833 | $0 | EDGAR |
| 2023-06-20 | AYTU | Buy (P) | +12,000 | $22.4K | EDGAR |
| 2022-12-21 | AYTU | Buy (P) | +100,000 | $24.5K | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.